Healthcare Fraud Detection Market Report
RA01261
Healthcare Fraud Detection Market, by Delivery Model (On-Premise, Cloud-Based), Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), Component (Software, Services), Application (Insurance Claims Review, Payment Integrity), End User (Private Insurance Payers, Public/Government Agencies, Third Party Service Providers): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global healthcare fraud detection market is estimated to surpass $7,449.1 million by 2027, exhibiting a CAGR of 29.8% from 2020 to 2027.
This report provides detailed insights on the present position and future perspective of the industry by deeply analyzing key factors of the market including major segments and regions, market drivers and restraints, rewarding investment opportunities, major players, and competitive outlook.
The report also furnishes the significant forces that are impacting market growth. Moreover, the report provides Porter’s Five Forces analysis which reveals the forte of prevailing players and the condition of the market in terms of growth and future opportunities. Furthermore, the report offers clear insights on the market size and scope by analyzing the global healthcare fraud detection market across different segments and sub-segments. The report offers detailed insights on the regional market condition of these segments and each segment is meticulously analyzed at regional as well as country level to get a broader scenario of the global healthcare fraud detection market. The report divides the global healthcare fraud detection market into four key regions including North America, Europe, Asia-Pacific, and LAMEA which are further segmented into major countries to cover the healthcare fraud detection market lookout in respective areas.
Additionally, competitive landscape of the global healthcare fraud detection market is deliberated in the report. Key players active in the global healthcare fraud detection market are also evaluated to understand their position in the global market. The report also provides information on product portfolio, company initiatives, winning business strategies, novel developments, and financial position of these players.
Research Methodology
We claim to offer our clients with reliable research and analysis garnered from various industry parameters and inputs such as recent trends, interview with participants of the industry, trustworthy sources of information & statistics, and regional acumen. Our expert market analysts have formulated this report by keenly scrutinizing every aspect of the market. Moreover, various top research and analysis approaches and tools have been used to draft this report with fine points, quality, and precision.
Various activities such as detailed deliberations and interviews with various leading investors and market professionals have been performed to collate every detail as well as driving forces of the global market. Both primary as well as secondary research techniques have been implemented for capturing detailed market predictions and forecasts. A huge variety of industry related documents such as industry releases, product type literatures, yearly reports, and others have been keenly studied for obtaining a clearer picture of the global healthcare fraud detection market scenario. Moreover, certified and renowned resources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and others have been reviewed to better understand the global market condition.
KEY MARKET BENEFITS
- This report caters detailed analysis, information, and valid inputs from industry specialists & contributors across the value chain
- The report offers an inclusive breakdown along with the latest trends and developments in the market during the forecast period from 2019 to 2027, thus highlighting upcoming investment opportunities and future scope of the market
- The report highlights all the major factors and events in the market from 2019 to 2027 and reveals the qualitative impact of other forces on market segments and geographies
- The report delivers reliable market forecasts and size by deeply scrutinizing key segments, driving and restraining factors, and recent & key developments by major players in the healthcare fraud detection market
- The report presents winning growth tactics and plans adopted by the key industry players for understanding the competitive landscape of the global healthcare fraud detection market
KEY MARKET SEGMENTS
The report deliberates the following segments of the market:
- Delivery Model: On-Premise, Cloud-Based
- Type: Descriptive Analytics, Predictive Analytics, Prescriptive Analytics
- Component: Software, Services
- Application: Insurance Claims Review, Payment Integrity
- End User: Private Insurance Payers, Public/Government Agencies, Third Party Service Providers
Region:
The global healthcare fraud detection market was evaluated across North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The report provides in-depth insights on the key players operating in the global healthcare fraud detection market. The major players enlisted in the report include UNITEDHEALTH group, CGI INC., DXC Technology Company, DXC Technology Company.
The report profiles several facts of all these key players as follows:
1. International Business Machines Corporation (IBM)
2. UNITEDHEALTH group
3. SAS Institute Inc.
4. FAIR ISAAC Corporation
5. McKesson Corporation
6. EXLSERVICE Holdings, Inc.
7. DXC Technology Company
8. LEXISNEXIS
9. COTIVITI INC.
10. WIPRO LIMITED
11. CGI INC.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Healthcare Fraud Detection Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Healthcare Fraud Detection Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Healthcare Fraud Detection Market, By Atrial Fibrillation Type
5.1. Overview
5.2 On-Premise
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Cloud-Based
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
-
6. Healthcare Fraud Detection Market, By Infections
6.1. Overview
6.2 Descriptive Analytics
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Predictive Analytics
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Prescriptive Analytics
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Research Dive Exclusive Insights
6.5.1 Market attractiveness
6.5.2 Competition heatmap
-
7. Healthcare Fraud Detection Market, By Structure
7.1. Overview
7.2 Software
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Services
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Research Dive Exclusive Insights
7.4.1 Market attractiveness
7.4.2 Competition heatmap
-
8. Healthcare Fraud Detection Market, By Resorbability
8.1. Overview
8.2 Insurance Claims Review
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Payment Integrity
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
-
9. Healthcare Fraud Detection Market,
9.1. Overview
9.2 Private Insurance Payers
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Public/Government Agencies
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Third Party Service Providers
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Research Dive Exclusive Insights
9.5.1 Market attractiveness
9.5.2 Competition heatmap
10. Healthcare Fraud Detection Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.1.1.2 Market size analysis, By Infections, 2020-2027
10.1.1.3 Market size analysis, By Structure, 2020-2027
10.1.1.4 Market size analysis, By Resorbability, 2020-2027
10.1.1.5 Market size analysis, , 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.1.2.2 Market size analysis, By Infections, 2020-2027
10.1.2.3 Market size analysis, By Structure, 2020-2027
10.1.2.4 Market size analysis, By Resorbability, 2020-2027
10.1.2.5 Market size analysis, , 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.1.3.2 Market size analysis, By Infections, 2020-2027
10.1.3.3 Market size analysis, By Structure, 2020-2027
10.1.3.4 Market size analysis, By Resorbability, 2020-2027
10.1.3.5 Market size analysis, , 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.2.1.2 Market size analysis, By Infections, 2020-2027
10.2.1.3 Market size analysis, By Structure, 2020-2027
10.2.1.4 Market size analysis, By Resorbability, 2020-2027
10.2.1.5 Market size analysis, , 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.2.2.2 Market size analysis, By Infections, 2020-2027
10.2.2.3 Market size analysis, By Structure, 2020-2027
10.2.2.4 Market size analysis, By Resorbability, 2020-2027
10.2.2.5 Market size analysis, , 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.2.3.2 Market size analysis, By Infections, 2020-2027
10.2.3.3 Market size analysis, By Structure, 2020-2027
10.2.3.4 Market size analysis, By Resorbability, 2020-2027
10.2.3.5 Market size analysis, , 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.2.4.2 Market size analysis, By Infections, 2020-2027
10.2.4.3 Market size analysis, By Structure, 2020-2027
10.2.4.4 Market size analysis, By Resorbability, 2020-2027
10.2.4.5 Market size analysis, , 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.2.5.2 Market size analysis, By Infections, 2020-2027
10.2.5.3 Market size analysis, By Structure, 2020-2027
10.2.5.4 Market size analysis, By Resorbability, 2020-2027
10.2.5.5 Market size analysis, , 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.2.6.2 Market size analysis, By Infections, 2020-2027
10.2.6.3 Market size analysis, By Structure, 2020-2027
10.2.6.4 Market size analysis, By Resorbability, 2020-2027
10.2.6.5 Market size analysis, , 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.3.1.2 Market size analysis, By Infections, 2020-2027
10.3.1.3 Market size analysis, By Structure, 2020-2027
10.3.1.4 Market size analysis, By Resorbability, 2020-2027
10.3.1.5 Market size analysis, , 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.3.2.2 Market size analysis, By Infections, 2020-2027
10.3.2.3 Market size analysis, By Structure, 2020-2027
10.3.2.4 Market size analysis, By Resorbability, 2020-2027
10.3.2.5 Market size analysis, , 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.3.3.2 Market size analysis, By Infections, 2020-2027
10.3.3.3 Market size analysis, By Structure, 2020-2027
10.3.3.4 Market size analysis, By Resorbability, 2020-2027
10.3.3.5 Market size analysis, , 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.3.4.2 Market size analysis, By Infections, 2020-2027
10.3.4.3 Market size analysis, By Structure, 2020-2027
10.3.4.4 Market size analysis, By Resorbability, 2020-2027
10.3.4.5 Market size analysis, , 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.3.5.2 Market size analysis, By Infections, 2020-2027
10.3.5.3 Market size analysis, By Structure, 2020-2027
10.3.5.4 Market size analysis, By Resorbability, 2020-2027
10.3.5.5 Market size analysis, , 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.3.6.2 Market size analysis, By Infections, 2020-2027
10.3.6.3 Market size analysis, By Structure, 2020-2027
10.3.6.4 Market size analysis, By Resorbability, 2020-2027
10.3.6.5 Market size analysis, , 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.4.1.2 Market size analysis, By Infections, 2020-2027
10.4.1.3 Market size analysis, By Structure, 2020-2027
10.4.1.4 Market size analysis, By Resorbability, 2020-2027
10.4.1.5 Market size analysis, , 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.4.2.2 Market size analysis, By Infections, 2020-2027
10.4.2.3 Market size analysis, By Structure, 2020-2027
10.4.2.4 Market size analysis, By Resorbability, 2020-2027
10.4.2.5 Market size analysis, , 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.4.3.2 Market size analysis, By Infections, 2020-2027
10.4.3.3 Market size analysis, By Structure, 2020-2027
10.4.3.4 Market size analysis, By Resorbability, 2020-2027
10.4.3.5 Market size analysis, , 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.4.4.2 Market size analysis, By Infections, 2020-2027
10.4.4.3 Market size analysis, By Structure, 2020-2027
10.4.4.4 Market size analysis, By Resorbability, 2020-2027
10.4.4.5 Market size analysis, , 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Atrial Fibrillation Type, 2020-2027
10.4.5.2 Market size analysis, By Infections, 2020-2027
10.4.5.3 Market size analysis, By Structure, 2020-2027
10.4.5.4 Market size analysis, By Resorbability, 2020-2027
10.4.5.5 Market size analysis, , 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 International Business Machines Corporation (IBM)
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 UNITEDHEALTH group
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 SAS Institute Inc.
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 FAIR ISAAC Corporation
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 McKesson Corporation
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 EXLSERVICE Holdings, Inc.
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 DXC Technology Company
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 LEXISNEXIS
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 COTIVITI INC.
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 WIPRO LIMITED
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
12.11 CGI INC.
12.11.1 Overview
12.11.2 Business segments
12.11.3 Product portfolio
12.11.4 Financial performance
12.11.5 Recent developments
12.11.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
